BVT Aktienanleihe AMD 28.03.2025/ DE000VD2UAL0 /
9/26/2024 1:57:24 PM | Chg.+0.740 | Bid4:37:45 PM | Ask4:37:45 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
97.650EUR | +0.76% | 97.700 Bid Size: 500,000 |
97.800 Ask Size: 500,000 |
ADVANCED MIC.DEV. D... | 145.00 - | 3/28/2025 | Call |
GlobeNewswire
9/1
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
8/27
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
8/27
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
8/26
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire
8/23
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular ...
GlobeNewswire
8/21
AMD 2023-24 Corporate Responsibility Report: Advancing Sustainability, Collaboration and Inclusion
GlobeNewswire
8/20
FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facil...
GlobeNewswire
8/20
Gamescom 2024 - HP Elevates the Gaming World through Customizable Solutions for a Personalized Playe...
GlobeNewswire
8/19
AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solut...
GlobeNewswire
8/16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
8/14
Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corp...